Startseite
Podcasts
Stephan Livera Podcast Podcast
The Bitcoin Strategy of Semler Scientific with Eric Semler | SLP641

The Bitcoin Strategy of Semler Scientific with Eric Semler | SLP641

Stephan Livera Podcast vor 1 Jahr

0:00

1:03:13

Eric Semler, chairman of Semler Scientific, shares his journey
from being an investor in technology and media to adopting a
Bitcoin treasury strategy for his company. He discusses the
origins of Semler Scientific, the challenges faced in the
healthcare sector, and how he became convinced of Bitcoin's
potential as a store of value.

Eric elaborates on the transition from personal conviction in
Bitcoin to implementing a corporate strategy, navigating
regulatory hurdles, and the evolution of Bitcoin treasury
strategies. He also addresses the concept of zombie companies and
their potential to benefit from adopting Bitcoin as part of their
financial strategy. The strategic timing for deploying Bitcoin in
business operations, the high hurdle rate associated with Bitcoin
investments, and the evolving landscape of Bitcoin treasury
companies are few of the other aspects discussed in depth.

Takeaways

Semler Scientific was founded 20 years ago by Eric's father.

The company focuses on medical devices, particularly for
screening peripheral artery disease.

Eric's journey with Bitcoin began in 2013 but solidified in 2017.

He was influenced by notable figures like Tom Lee and Michael
Saylor.

The company adopted a Bitcoin treasury strategy in May 2021.

They faced regulatory challenges with the SEC during the adoption
process.

The board was supportive of the Bitcoin strategy despite initial
skepticism.

Eric believes that many companies should adopt a Bitcoin treasury
strategy.

Zombie companies are those with cash but lack growth and market
interest.

Eric advocates for these companies to consider Bitcoin as a
valuable asset. Tech CEOs may personally hold Bitcoin but
hesitate to adopt it for their companies.

Advising zombie companies to start with small Bitcoin investments
can be effective.

Calling a company a 'zombie' can be insulting and
counterproductive.

Companies should focus on accumulating Bitcoin rather than using
it for operations.

The hurdle rate for Bitcoin investments is exceptionally high.

Market saturation could impact the success of Bitcoin treasury
companies.

Institutional investors have strict mandates that limit direct
Bitcoin purchases.

The current market drawdown may deter companies from investing in
Bitcoin.

Long-term strategies are essential for navigating Bitcoin's
volatility.

The potential for Bitcoin to exceed gold's value presents
significant opportunities.

Timestamps:

(00:00) - Intro

(01:54) - The story of Semler Scientific

(06:09) - How did Eric stumble down the Bitcoin rabbit hole?

(09:10) - Semler Scientific adopting the Bitcoin Treasury
Strategy

(16:34) - Convincing the stakeholders and the board of Semler
Scientific to adopt BTC

(18:32) - Exploring financial engineering to buy more Bitcoin

(20:42) - Sponsors

(22:57) - Semler Scientific’s value as a MedTech & Bitcoin
Treasury company

(26:38) - How is the debt structured to acquire more Bitcoin?

(29:02) - What is the future of Bitcoin Treasury Companies?

(31:40) - What is a zombie company?; The case for Bitcoin in
zombie companies

(36:00) - The role of Tech CEOs in Bitcoin adoption

(37:29) - Advising zombie companies on Bitcoin

(39:27) - Sponsors

(40:39) - Are zombie companies sensitive to criticism?

(43:58) - When should a company deploy Bitcoin in its business
strategies?

(46:45) - Should Bitcoin be a hurdle rate for investments?

(51:18) - Bitcoin treasury companies managing market saturation

(54:39) - Understanding the investor landscape for Bitcoin
Treasuries

(59:33) - How does Semler navigate bear cycles?

(1:01:53) - Closing thoughts

Links:

https://x.com/SemlerEric

https://www.semlerscientific.com/

https://x.com/SemlerEric/status/1892924967940993250

Sponsors:

Bold Bitcoin

CoinKite.com (code LIVERA)

Lana by Galoy

Stephan Livera links:

Follow me on X: @stephanlivera

Subscribe to the podcast

Subscribe to Substack